Filed: 2/14/2024ACC: 0001802630-24-000003
📋 What this filing means
SOLEUS CAPITAL MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 73 equity positions with a total reported market value of $901.25M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
73
Positions
$901.25M
Total AUM (reported)
94.38M
Total Shares
Allocation by class
COM$611.44M67.8%
SPONSORED ADR$85.54M9.5%
COM NEW$71.09M7.9%
SPONSORED ADS$68.25M7.6%
SPON ADS$22.59M2.5%
SPDN ADR NEW$12.83M1.4%
COM STK$10.37M1.2%
Portfolio Concentration
Top 3$160.33M17.8%
4–10$245.82M27.3%
11–25$289.25M32.1%
Rest$205.85M22.8%
Top 3 weight
17.8%
Top 10 weight
45.1%
Voting Authority Distribution
Total shares with voting rights: 94.38M
Sole
Full voting authority
94.38M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole73
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings73
Rows:
TEVA PHARMACEUTICAL INDS LTD
SOLEShares5.56M
TypeSH
Market value$58.09M
6.45%
Sole
5.56M
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares249.45K
TypeSH
Market value$54.85M
6.09%
Sole
249.45K
Shared
0.00
None
0.00
GSK PLC
SOLEShares1.28M
TypeSH
Market value$47.38M
5.26%
Sole
1.28M
Shared
0.00
None
0.00
RAYZEBIO INC
SOLEShares746.62K
TypeSH
Market value$46.42M
5.15%
Sole
746.62K
Shared
0.00
None
0.00
EDAP TMS S A
SOLEShares7.23M
TypeSH
Market value$38.16M
4.23%
Sole
7.23M
Shared
0.00
None
0.00
ORGANOGENESIS HLDGS INC
SOLEShares8.96M
TypeSH
Market value$36.66M
4.07%
Sole
8.96M
Shared
0.00
None
0.00
HUMANA INC
SOLEShares73.71K
TypeSH
Market value$33.74M
3.74%
Sole
73.71K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares2.18M
TypeSH
Market value$31.76M
3.52%
Sole
2.18M
Shared
0.00
None
0.00
IRADIMED CORP
SOLEShares643.21K
TypeSH
Market value$30.53M
3.39%
Sole
643.21K
Shared
0.00
None
0.00
ESSA PHARMA INC
SOLEShares4.33M
TypeSH
Market value$28.56M
3.17%
Sole
4.33M
Shared
0.00
None
0.00
SURMODICS INC
SOLEShares771.70K
TypeSH
Market value$28.05M
3.11%
Sole
771.70K
Shared
0.00
None
0.00
HCA HEALTHCARE INC
SOLEShares101.50K
TypeSH
Market value$27.47M
3.05%
Sole
101.50K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares415.45K
TypeSH
Market value$26.09M
2.89%
Sole
415.45K
Shared
0.00
None
0.00
NEUROPACE INC
SOLEShares2.43M
TypeSH
Market value$25.09M
2.78%
Sole
2.43M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares322.89K
TypeSH
Market value$23.76M
2.64%
Sole
322.89K
Shared
0.00
None
0.00
MEREO BIOPHARMA GROUP PLC
SOLEShares9.78M
TypeSH
Market value$22.59M
2.51%
Sole
9.78M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares564.70K
TypeSH
Market value$20.09M
2.23%
Sole
564.70K
Shared
0.00
None
0.00
PENUMBRA INC
SOLEShares79.40K
TypeSH
Market value$19.97M
2.22%
Sole
79.40K
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares2.60M
TypeSH
Market value$17.73M
1.97%
Sole
2.60M
Shared
0.00
None
0.00
ATRICURE INC
SOLEShares392.19K
TypeSH
Market value$14.00M
1.55%
Sole
392.19K
Shared
0.00
None
0.00
RIGEL PHARMACEUTICALS INC
SOLEShares9.44M
TypeSH
Market value$13.69M
1.52%
Sole
9.44M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares317.05K
TypeSH
Market value$13.36M
1.48%
Sole
317.05K
Shared
0.00
None
0.00
TREACE MED CONCEPTS INC
SOLEShares1.01M
TypeSH
Market value$12.93M
1.43%
Sole
1.01M
Shared
0.00
None
0.00
SMITH & NEPHEW PLC
SOLEShares470.20K
TypeSH
Market value$12.83M
1.42%
Sole
470.20K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares1.43M
TypeSH
Market value$11.60M
1.29%
Sole
1.43M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 5.56M | SH | $58.09M 6.45% | 5.56M | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 249.45K | SH | $54.85M 6.09% | 249.45K | 0.00 | 0.00 |
GSK PLCSOLE | SPONSORED ADR | 1.28M | SH | $47.38M 5.26% | 1.28M | 0.00 | 0.00 |
RAYZEBIO INCSOLE | COM | 746.62K | SH | $46.42M 5.15% | 746.62K | 0.00 | 0.00 |
EDAP TMS S ASOLE | SPONSORED ADR | 7.23M | SH | $38.16M 4.23% | 7.23M | 0.00 | 0.00 |
ORGANOGENESIS HLDGS INCSOLE | COM | 8.96M | SH | $36.66M 4.07% | 8.96M | 0.00 | 0.00 |
HUMANA INCSOLE | COM | 73.71K | SH | $33.74M 3.74% | 73.71K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 2.18M | SH | $31.76M 3.52% | 2.18M | 0.00 | 0.00 |
IRADIMED CORPSOLE | COM | 643.21K | SH | $30.53M 3.39% | 643.21K | 0.00 | 0.00 |
ESSA PHARMA INCSOLE | COM NEW | 4.33M | SH | $28.56M 3.17% | 4.33M | 0.00 | 0.00 |
SURMODICS INCSOLE | COM | 771.70K | SH | $28.05M 3.11% | 771.70K | 0.00 | 0.00 |
HCA HEALTHCARE INCSOLE | COM | 101.50K | SH | $27.47M 3.05% | 101.50K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 415.45K | SH | $26.09M 2.89% | 415.45K | 0.00 | 0.00 |
NEUROPACE INCSOLE | COM | 2.43M | SH | $25.09M 2.78% | 2.43M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 322.89K | SH | $23.76M 2.64% | 322.89K | 0.00 | 0.00 |
MEREO BIOPHARMA GROUP PLCSOLE | SPON ADS | 9.78M | SH | $22.59M 2.51% | 9.78M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 564.70K | SH | $20.09M 2.23% | 564.70K | 0.00 | 0.00 |
PENUMBRA INCSOLE | COM | 79.40K | SH | $19.97M 2.22% | 79.40K | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 2.60M | SH | $17.73M 1.97% | 2.60M | 0.00 | 0.00 |
ATRICURE INCSOLE | COM | 392.19K | SH | $14.00M 1.55% | 392.19K | 0.00 | 0.00 |
RIGEL PHARMACEUTICALS INCSOLE | COM NEW | 9.44M | SH | $13.69M 1.52% | 9.44M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 317.05K | SH | $13.36M 1.48% | 317.05K | 0.00 | 0.00 |
TREACE MED CONCEPTS INCSOLE | COM | 1.01M | SH | $12.93M 1.43% | 1.01M | 0.00 | 0.00 |
SMITH & NEPHEW PLCSOLE | SPDN ADR NEW | 470.20K | SH | $12.83M 1.42% | 470.20K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 1.43M | SH | $11.60M 1.29% | 1.43M | 0.00 | 0.00 |
Page 1 of 3